L-Arginine infusion increases glucose clearance during prolonged exercise in humans.
暂无分享,去创建一个
[1] W. Saris,et al. Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans. , 2005, American journal of physiology. Endocrinology and metabolism.
[2] B. Knechtle,et al. Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized, double-blind, placebo-controlled study. , 2005, International journal of sports medicine.
[3] E. Barrett,et al. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats. , 2004, American journal of physiology. Endocrinology and metabolism.
[4] H. Gunga,et al. Differential expression of nitric oxide synthases (NOS 1‐3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] G. McConell,et al. 5′‐AMINOIMIDAZOLE‐4‐CARBOXYAMIDE‐RIBONUCLEOSIDE‐ACTIVATED GLUCOSE TRANSPORT IS NOT PREVENTED BY NITRIC OXIDE SYNTHASE INHIBITION IN RAT ISOLATED SKELETAL MUSCLE , 2004, Clinical and experimental pharmacology & physiology.
[6] Christopher J. Davidson,et al. High-fat diet elevates resting intramuscular triglyceride concentration and whole body lipolysis during exercise. , 2004, American journal of physiology. Endocrinology and metabolism.
[7] Y. Hellsten,et al. Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions. , 2003, Free radical biology & medicine.
[8] E. Barrett,et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. , 2003, American journal of physiology. Endocrinology and metabolism.
[9] B. Kingwell,et al. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. , 2002, Diabetes.
[10] J. Rottman,et al. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. , 2002, American journal of physiology. Endocrinology and metabolism.
[11] W. Derave,et al. Glucose, exercise and insulin: emerging concepts , 2001, The Journal of physiology.
[12] J. Ritter,et al. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. , 2001, Journal of the American College of Cardiology.
[13] N. Christensen,et al. Interaction between β-Adrenergic Receptor Stimulation and Nitric Oxide Release on Tissue Perfusion and Metabolism1 , 2001 .
[14] Judy W. M. Cheng,et al. L-Arginine in the Management of Cardiovascular Diseases , 2001, The Annals of pharmacotherapy.
[15] K. Alberti,et al. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. , 2001, Diabetes care.
[16] D. Bernstein,et al. L-arginine enhances aerobic exercise capacity in association with augmented nitric oxide production. , 2001, Journal of applied physiology.
[17] Y. Hellsten,et al. Exercise‐induced hyperaemia and leg oxygen uptake are not altered during effective inhibition of nitric oxide synthase with NG‐nitro‐l‐arginine methyl ester in humans , 2001, The Journal of physiology.
[18] N. Fujii,et al. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. , 2001, Diabetes.
[19] N. Christensen,et al. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. , 2001, The Journal of clinical endocrinology and metabolism.
[20] P. Klatt,et al. Nitric oxide inhibits isoproterenol-stimulated adipocyte lipolysis through oxidative inactivation of the beta-agonist. , 2000, The Biochemical journal.
[21] Y. Hellsten,et al. Endurance training does not alter the level of neuronal nitric oxide synthase in human skeletal muscle. , 2000, Journal of applied physiology.
[22] C. Han,et al. Nitric oxide inhibits norepinephrine-induced hepatic vascular responses but potentiates hepatic glucose output. , 1999, Canadian journal of physiology and pharmacology.
[23] W. Langhans,et al. Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run , 1999, European journal of nutrition.
[24] B. Kingwell,et al. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. , 1999, Diabetes.
[25] G. McConell,et al. Muscle metabolism during prolonged exercise in humans: influence of carbohydrate availability. , 1999, Journal of applied physiology.
[26] C. Roberts,et al. Acute exercise increases nitric oxide synthase activity in skeletal muscle. , 1999, American journal of physiology. Endocrinology and metabolism.
[27] B. Saltin,et al. Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. , 1999, American journal of physiology. Heart and circulatory physiology.
[28] Motoyuki Nakamura,et al. Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure , 1999, Heart.
[29] E. Horton,et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. , 1999, Diabetes.
[30] P. Arner,et al. A nitric oxide‐mediated mechanism regulates lipolysis in human adipose tissue in vivo , 1999, British journal of pharmacology.
[31] A E Jeukendrup,et al. Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion , 1999, The Journal of physiology.
[32] G. Brabant,et al. L-arginine stimulates NO-dependent vasodilation in healthy humans--effect of somatostatin pretreatment. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[33] D. Tsikas,et al. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. , 1998, British journal of clinical pharmacology.
[34] A. Quyyumi. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. , 1998, Journal of the American College of Cardiology.
[35] Y. Giudicelli,et al. Modulation of White Adipose Tissue Lipolysis by Nitric Oxide* , 1998, The Journal of Biological Chemistry.
[36] P. Chowienczyk,et al. Haemodynamic effects of inhibition of nitric oxide synthase and of L‐arginine at rest and during exercise , 1998, Journal of hypertension.
[37] M. Hollidge-Horvat,et al. Effects of increased fat availability on fat-carbohydrate interaction during prolonged exercise in men. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[38] M. Young,et al. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. , 1998, The Biochemical journal.
[39] Tatsuya Hayashi,et al. Exercise regulation of glucose transport in skeletal muscle. , 1997, The American journal of physiology.
[40] G. Etgen,et al. Nitric Oxide Stimulates Skeletal Muscle Glucose Transport Through a Calcium/Contraction– and Phosphatidylinositol-3-Kinase–Independent Pathway , 1997, Diabetes.
[41] L. Ceremużyński,et al. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. , 1997, The American journal of cardiology.
[42] W. Kohrt,et al. Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans. , 1997, The American journal of physiology.
[43] C. Roberts,et al. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. , 1997, The American journal of physiology.
[44] J. Nadler,et al. Evidence that nitric oxide increases glucose transport in skeletal muscle. , 1997, Journal of applied physiology.
[45] Y. Hellsten,et al. Localization of nitric oxide synthase in human skeletal muscle. , 1996, Biochemical and biophysical research communications.
[46] G. McConell,et al. Effect of timing of carbohydrate ingestion on endurance exercise performance. , 1996, Medicine and science in sports and exercise.
[47] T. Rector,et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. , 1996, Circulation.
[48] P. Hespel,et al. Significance of Insulin for Glucose Metabolism in Skeletal Muscle During Contractions , 1996, Diabetes.
[49] A Jeukendrup,et al. A new validated endurance performance test. , 1996, Medicine and science in sports and exercise.
[50] E. Granström,et al. Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia. , 1995, Atherosclerosis.
[51] E. Coyle,et al. Relationship between fatty acid delivery and fatty acid oxidation during strenuous exercise. , 1995, Journal of applied physiology.
[52] O. Pedersen,et al. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Holloszy,et al. Wortmannin inhibits insulin‐stimulated but not contraction‐stimulated glucose transport activity in skeletal muscle , 1995, FEBS letters.
[54] M. Febbraio,et al. Effect of carbohydrate ingestion on glucose kinetics during exercise. , 2001, Journal of applied physiology.
[55] S. Bode-Böger,et al. Exercise increases systemic nitric oxide production in men. , 1995, Journal of cardiovascular risk.
[56] J. Nadler,et al. Nitric oxide release is present from incubated skeletal muscle preparations. , 1994, Journal of applied physiology.
[57] H. Esumi,et al. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. , 1992, Japanese heart journal.
[58] E. Richter,et al. Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. , 1991, Journal of applied physiology.
[59] D. James,et al. Exercise-induced hepatic glucose output is precisely sensitive to the rate of systemic glucose supply. , 1985, Metabolism: clinical and experimental.
[60] R. DeFronzo,et al. The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.
[61] W. Waldhäusl,et al. Influence of Arginine on Splanchnic Glucose Metabolism in Man , 1979, Diabetes.
[62] K.,et al. Experimental validation of measurements of glucose turnover in nonsteady state. , 1978, The American journal of physiology.
[63] G. Borg,et al. Perceived exertion: a note on "history" and methods. , 1973, Medicine and science in sports.
[64] S. Chernick. [58] Determination of glycerol in acyl glycerols , 1969 .
[65] R. Steele,et al. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.